Open
Early factor XIII replacement in postpartum hemorrhage: multi-center randomized controlled trial
Grant from Swiss National Science Foundation
The grant funds a multi-center randomized controlled trial on early factor XIII replacement in postpartum hemorrhage, with an approved amount of 3,049,831 CHF, led by Christian Haslinger, and is ongoing from 31.08.2023 to 30.08.2028.
- Funder
- Swiss National Science Foundation
- Award amount
- Up to $3,049,831
- Deadline
- August 31, 2028
- Status
- Open
- Who can apply
- Institutions, Researchers
- Focus
- Maternal health, Research
- Official source
- data.snf.ch
Open in GrantAuthority. The full listing, application link, requirements, attachments, program contacts and your organization's fit score are available with a free account.
Similar open grants
- Ooredoo Myanmar
BRAC International (operating in Madagascar) - Maternal and newborn thematic health fund
UNFPA - How we fund research
Tommys Baby Charity - IMPLICIT Grant Program – Wellshare International
MINNESOTA COMMUNITY HEALTH WORKER - Regional Maternal Health Coalitions
pa.gov - Philly Birth Fund
PHILLY BIRTH FUND